Share：
Share this content in WeChat
X
[Chinese] [PDF] 170 7
• Review •
Clinical application advances of cardiac magnetic resonance in assessing right atrial function
MA Xiaoyan  LI Shibo  PENG Zhengxuan  ZHOU Xing 

DOI:10.12015/issn.1674-8034.2025.08.030.


[Abstract] The right atrial structure and function play a pivotal role in maintaining cardiovascular homeostasis, with its structural remodeling and functional abnormalities closely linked to the pathological progression of various cardiovascular diseases. In recent years, the rapid advancement of cardiac magnetic resonance (CMR) technology has demonstrated unique advantages in non-invasive assessment of cardiac anatomy, function, and myocardial tissue characteristics, providing novel perspectives and methodologies for precise evaluation of right atrial function. This article focuses on elaborating the common parameters for evaluating right atrial function by CMR and delves into its clinical applications in various cardiovascular diseases. It points out the current research deficiencies and challenges in the field of right atrial function assessment by CMR and indicates the future research directions. The aim of this article is to enhance the comprehensive understanding of CMR in evaluating right atrial function, promote its wide application in the diagnosis and treatment of cardiovascular diseases, and provide references for the early diagnosis, disease assessment and prognosis judgment of the diseases.
[Keywords] right atrium；heart failure；cardiomyopathy；magenetic resonance imaging；cardiac magnetic resonance；myocardial strain；functional assessment

MA Xiaoyan1   LI Shibo1   PENG Zhengxuan1   ZHOU Xing2*  

1 Gansu University of Chinese Medicine, Lanzhou 730000, China

2 Department of Radiology, Gansu Provincial People's Hospital, Lanzhou 730000, China

Corresponding author: ZHOU X, E-mail: xingzhoulzu@163.com

Conflicts of interest   None.

Received  2025-05-26
Accepted  2025-08-05
DOI: 10.12015/issn.1674-8034.2025.08.030
DOI:10.12015/issn.1674-8034.2025.08.030.

[1]
KARKI R, RAINA A, EZZEDDINE F M, et al. Anatomy and pathology of the cardiac conduction system[J]. Cardiol Clin, 2023, 41(3): 277-292. DOI: 10.1016/j.ccl.2023.03.016.
[2]
NISHIHARA T, TAKAYA Y, NAKAYAMA R, et al. Prognostic value of right atrial function in patients with significant tricuspid regurgitation[J]. ESC Heart Fail, 2024, 11(6): 4019-4027. DOI: 10.1002/ehf2.14846.
[3]
PARLATI A L M, NARDI E, MARZANO F, et al. Advancing cardiovascular diagnostics: the expanding role of CMR in heart failure and cardiomyopathies[J/OL]. J Clin Med, 2025, 14(3): 865 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/39941536/. DOI: 10.3390/jcm14030865.
[4]
MATUSIK P S, MIKRUT K, BRYLL A, et al. Cardiac magnetic resonance imaging in diagnostics and cardiovascular risk assessment[J/OL]. Diagnostics (Basel), 2025, 15(2): 178 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/39857062/. DOI: 10.3390/diagnostics15020178.
[5]
WANG Y J, YANG K, WEN Y, et al. Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging[J]. Nat Med, 2024, 30(5): 1471-1480. DOI: 10.1038/s41591-024-02971-2.
[6]
LIU T, GAO Y F, WANG H, et al. Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy[J]. Heart, 2021, 107(15): 1233-1239. DOI: 10.1136/heartjnl-2020-317949.
[7]
QIAN Y F, ZHAO X H, CHEN B H, et al. Right ventricular global strain in patients with hypertrophic cardiomyopathy with and without right ventricular hypertrophy[J/OL]. Eur J Radiol, 2023, 169: 111148 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/37871355/. DOI: 10.1016/j.ejrad.2023.111148.
[8]
NEGRU A, TARCĂU B M, AGOSTON-COLDEA L. Cardiac magnetic resonance imaging in the evaluation of functional impairments in the right heart[J/OL]. Diagnostics (Basel), 2024, 14(22): 2581 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/39594247/. DOI: 10.3390/diagnostics14222581.
[9]
KLEMENZ A C, REICHARDT L, GORODEZKY M, et al. Accelerated cardiac MRI with deep learning-based image reconstruction for cine imaging[J/OL]. Radiol Cardiothorac Imaging, 2024, 6(6): e230419 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/39540821/. DOI: 10.1148/ryct.230419.
[10]
RUSSO V, LOVATO L, LIGABUE G. Cardiac MRI: technical basis[J]. Radiol Med, 2020, 125(11): 1040-1055. DOI: 10.1007/s11547-020-01282-z.
[11]
WANG Y J, GAO H, LI Y, et al. Estimating bilateral atrial function by cardiovascular magnetic resonance feature tracking in patients with paroxysmal atrial fibrillation[J/OL]. J Vis Exp, 2022(185): (185) [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/35938800/. DOI: 10.3791/63598.
[12]
IVANOV A, MOHAMED A, ASFOUR A, et al. Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction[J/OL]. PLoS One, 2017, 12(4): e0173245 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/28369148/. DOI: 10.1371/journal.pone.0173245.
[13]
CHADALAVADA S, FUNG K, RAUSEO E, et al. Myocardial strain measured by cardiac magnetic resonance predicts cardiovascular morbidity and death[J]. J Am Coll Cardiol, 2024, 84(7): 648-659. DOI: 10.1016/j.jacc.2024.05.050.
[14]
ZHENG J Y, CHEN B H, WU R, et al. Prognostic value of right atrial strains in arrhythmogenic right ventricular cardiomyopathy[J/OL]. Insights Imaging, 2024, 15(1): 58 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/38411736/. DOI: 10.1186/s13244-024-01630-x.
[15]
XU J, YANG W J, ZHAO S H, et al. State-of-the-art myocardial strain by CMR feature tracking: clinical applications and future perspectives[J]. Eur Radiol, 2022, 32(8): 5424-5435. DOI: 10.1007/s00330-022-08629-2.
[16]
AQUARO G D, DE GORI C, FAGGIONI L, et al. Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies[J/OL]. Eur Heart J Suppl, 2023, 25(Suppl C): C130-C136 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/37125322/. DOI: 10.1093/eurheartjsupp/suad015.
[17]
ZHAO K D, CAO X S. Research progress of T1 mapping MRI in dilated cardiomyopathy[J]. Chin J Magn Reson Imag, 2024, 15(5): 204-208. DOI: 10.12015/issn.1674-8034.2024.05.033.
[18]
LUO R L, SUN Q, ZHAO Y, et al. Segmental evaluation of myocardial ischemia in stable coronary artery disease using native T1 mapping[J/OL]. Magn Reson Imaging, 2025, 122: 110456 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/40633853/. DOI: 10.1016/j.mri.2025.110456.
[19]
MACEIRA A M, COSÍN-SALES J, ROUGHTON M, et al. Reference right atrial dimensions and volume estimation by steady state free precession cardiovascular magnetic resonance[J/OL]. J Cardiovasc Magn Reson, 2013, 15(1): 29 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/23566426/. DOI: 10.1186/1532-429X-15-29.
[20]
GAO Y Y, ZHANG Z, GUO L N, et al. Age- and sex-specific MR-feature tracking reference values of right atrial deformation in healthy adults[J]. J Magn Reson Imaging, 2025, 61(1): 263-273. DOI: 10.1002/jmri.29339.
[21]
HUMBERT M, KOVACS G, HOEPER M M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Heart J, 2022, 43(38): 3618-3731. DOI: 10.1093/eurheartj/ehac237.
[22]
YASENJIANG M, CHENG H, GUO Z T, et al. Correlation between pulmonary vascular performance and hemodynamics in patients with pulmonary arterial hypertension[J/OL]. Clin Exp Hypertens, 2023, 45(1): 2185253 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/36906960/. DOI: 10.1080/10641963.2023.2185253.
[23]
VOS J L, LEINER T, VAN DIJK A J, et al. Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension[J]. Int J Cardiovasc Imaging, 2022, 38(8): 1699-1710. DOI: 10.1007/s10554-022-02555-6.
[24]
RICHTER M J, FORTUNI F, ALENEZI F, et al. Imaging the right atrium in pulmonary hypertension: a systematic review and meta-analysis[J]. J Heart Lung Transplant, 2023, 42(4): 433-446. DOI: 10.1016/j.healun.2022.11.007.
[25]
TELLO K, DALMER A, VANDERPOOL R, et al. Right ventricular function correlates of right atrial strain in pulmonary hypertension: a combined cardiac magnetic resonance and conductance catheter study[J/OL]. Am J Physiol Heart Circ Physiol, 2020, 318(1): H156-H164 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/31756118/. DOI: 10.1152/ajpheart.00485.2019.
[26]
HEIDENREICH P A, BOZKURT B, AGUILAR D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines[J/OL]. Circulation, 2022, 145(18): e876-e894 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/35363500/. DOI: 10.1161/CIR.0000000000001062.
[27]
JAIN S, KURIAKOSE D, EDELSTEIN I, et al. Right atrial phasic function in heart failure with preserved and reduced ejection fraction[J]. JACC Cardiovasc Imaging, 2019, 12(8Pt 1): 1460-1470. DOI: 10.1016/j.jcmg.2018.08.020.
[28]
SCHÖNBAUER R, HANA F, DUCA F, et al. Right atrial phasic function in heart failure with preserved ejection fraction: cardiac magnetic resonance feature tracking and outcomes[J/OL]. J Clin Med, 2023, 12(16): 5179 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/37629221/. DOI: 10.3390/jcm12165179.
[29]
HEYMANS S, LAKDAWALA N K, TSCHÖPE C, et al. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches[J]. Lancet, 2023, 402(10406): 998-1011. DOI: 10.1016/S0140-6736(23)01241-2.
[30]
LI Y J, GUO J J, LI W H, et al. Prognostic value of right atrial strain derived from cardiovascular magnetic resonance in non-ischemic dilated cardiomyopathy[J/OL]. J Cardiovasc Magn Reson, 2022, 24(1): 54 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/36352424/. DOI: 10.1186/s12968-022-00894-w.
[31]
GAO Y Y, PU C L, LI Q, et al. Assessment of right atrial function measured with cardiac MRI feature tracking for predicting outcomes in patients with dilated cardiomyopathy[J/OL]. Radiology, 2024, 310(3): e232388 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/38470238/. DOI: 10.1148/radiol.232388.
[32]
MARON B J, DESAI M Y, NISHIMURA R A, et al. Diagnosis and evaluation of hypertrophic cardiomyopathy JACC state-of-the-art review[J]. J Am Coll Cardiol, 2022, 79(4): 372-389. DOI: 10.1016/j.jacc.2021.12.002.
[33]
LI H W, WANG H B, WANG T T, et al. Different phenotype of left atrial function impairment in patients with hypertrophic cardiomyopathy and hypertension: comparison of healthy controls[J/OL]. Front Cardiovasc Med, 2023, 10: 1027665 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/37234371/. DOI: 10.3389/fcvm.2023.1027665.
[34]
KRAHN A D, WILDE A A M, CALKINS H, et al. Arrhythmogenic right ventricular cardiomyopathy[J]. JACC Clin Electrophysiol, 2022, 8(4): 533-553. DOI: 10.1016/j.jacep.2021.12.002.
[35]
KO D, CHUNG M K, EVANS P T, et al. Atrial fibrillation: a review[J]. JAMA, 2025, 333(4): 329-342. DOI: 10.1001/jama.2024.22451.
[36]
XIE E, YU R, AMBALE-VENKATESH B, et al. Association of right atrial structure with incident atrial fibrillation: a longitudinal cohort cardiovascular magnetic resonance study from the Multi-Ethnic Study of Atherosclerosis (MESA)[J/OL]. J Cardiovasc Magn Reson, 2020, 22(1): 36 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/32434529/. DOI: 10.1186/s12968-020-00631-1.
[37]
GUENSCH D P, KUGANATHAN S, UTZ C D, et al. Analysis of bi-atrial function using CMR feature tracking and long-axis shortening approaches in patients with diastolic dysfunction and atrial fibrillation[J]. Eur Radiol, 2023, 33(10): 7226-7237. DOI: 10.1007/s00330-023-09663-4.
[38]
HOPMAN L H G A, VISCH J E, BHAGIRATH P, et al. Right atrial function and fibrosis in relation to successful atrial fibrillation ablation[J]. Eur Heart J Cardiovasc Imaging, 2023, 24(3): 336-345. DOI: 10.1093/ehjci/jeac152.
[39]
PASQUALIN G, BOCCELLINO A, CHESSA M, et al. Ebstein's anomaly in children and adults: multidisciplinary insights into imaging and therapy[J]. Heart, 2024, 110(4): 235-244. DOI: 10.1136/heartjnl-2023-322420.
[40]
CIEPŁUCHA A, TROJNARSKA O, KOCIEMBA A, et al. Clinical aspects of myocardial fibrosis in adults with Ebstein's anomaly[J]. Heart Vessels, 2018, 33(9): 1076-1085. DOI: 10.1007/s00380-018-1141-5.
[41]
O'NEILL L, SIM I, O'HARE D, et al. CArdiac MagnEtic resonance assessment of bi-Atrial fibrosis in secundum atrial septal defects patients: CAMERA-ASD study[J]. Eur Heart J Cardiovasc Imaging, 2022, 23(9): 1231-1239. DOI: 10.1093/ehjci/jeab188.
[42]
SOHNS J M, ROSENBERG C, ZAPF A, et al. Right atrial volume is increased in corrected tetralogy of fallot and correlates with the incidence of supraventricular arrhythmia: a CMR study[J]. Pediatr Cardiol, 2015, 36(6): 1239-1247. DOI: 10.1007/s00246-015-1152-2.
[43]
KUTTY S, SHANG Q L, JOSEPH N, et al. Abnormal right atrial performance in repaired tetralogy of Fallot: a CMR feature tracking analysis[J/OL]. Int J Cardiol, 2017, 248: 136-142 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/28712562/. DOI: 10.1016/j.ijcard.2017.06.121.
[44]
DICK A, SCHMIDT B, MICHELS G, et al. Left and right atrial feature tracking in acute myocarditis: a feasibility study[J/OL]. Eur J Radiol, 2017, 89: 72-80 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/28267553/. DOI: 10.1016/j.ejrad.2017.01.028.
[45]
TANG Y Y, YANG Z X, WEN J Y, et al. Association of serum uric acid with right cardiac chamber remodeling assessed by cardiovascular magnetic resonance feature tracking in patients with connective tissue disease[J/OL]. Front Endocrinol (Lausanne), 2024, 15: 1351197 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/38586451/. DOI: 10.3389/fendo.2024.1351197.
[46]
SAKAI A, NAGAO M, YAMAMOTO A, et al. Prognostic value of right atrial strain in systemic sclerosis based on tissue tracking analysis using cine cardiac magnetic resonance imaging: a retrospective observational study[J]. Heart Vessels, 2024, 39(2): 135-143. DOI: 10.1007/s00380-023-02320-2.
[47]
KNIGHT D S, VIRSINSKAITE R, KARIA N, et al. Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension[J]. Rheumatology (Oxford), 2024, 63(10): 2678-2683. DOI: 10.1093/rheumatology/keae141.
[48]
SINGH T, KHAN H, GAMBLE D T, et al. Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications[J]. Circulation, 2022, 145(13): 1002-1019. DOI: 10.1161/CIRCULATIONAHA.121.055854.
[49]
BACKHAUS S J, STIERMAIER T, LANGE T, et al. Atrial mechanics and their prognostic impact in Takotsubo syndrome: a cardiovascular magnetic resonance imaging study[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(9): 1059-1069. DOI: 10.1093/ehjci/jey219.
[50]
CAU R, LOEWE C, CHERCHI V, et al. Atrial impairment as a marker in discriminating between takotsubo and acute myocarditis using cardiac magnetic resonance[J/OL]. J Thorac Imaging, 2022, 37(6): W78-W84 [2025-05-25]. https://pubmed.ncbi.nlm.nih.gov/36306267/. DOI: 10.1097/RTI.0000000000000650.

PREV Advances in cardiac magnetic resonance imaging of cardiomyopathy associated with metabolic abnormalities
NEXT Research progress on predicting the prognosis of nasopharyngeal carcinoma based on magnetic resonance imaging features
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn